Literature DB >> 1647133

Characterisation of the binding of the histamine H3 receptor agonist [3H] (R)-alpha methyl histamine to homogenates of rat and guinea-pig cortex.

G J Kilpatrick1, A D Michel.   

Abstract

We have examined the specific binding of [3H] (R)-alpha-methyl histamine to homogenates of rat and guinea-pig cerebral cortex. Using rat cortex, specific binding represented 90% of total binding. This specific binding was saturable (Bmax 131 fmol/mg protein) of high affinity (Kd 0.40 nM) and reversible. H3 receptor agonists and antagonists potently competed for binding. Antagonist affinities correlated with those reported in functional assays. Affinities derived using guinea-pig cortex were similar to those from rat cortex. GTP inhibited binding (IC50 181 microM). Magnesium ions caused no increase in specific binding but inhibited binding at low mM concentrations. Sodium ions inhibited binding at physiological concentrations (IC50 44 mM).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647133     DOI: 10.1007/978-3-0348-7309-3_4

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  9 in total

1.  Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.

Authors:  David G Witte; Betty Bei Yao; Thomas R Miller; Tracy L Carr; Steven Cassar; Rahul Sharma; Ramin Faghih; Bruce W Surber; Timothy A Esbenshade; Arthur A Hancock; Kathleen M Krueger
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

2.  Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.

Authors:  Florence Gbahou; Ludwig Vincent; Marie Humbert-Claude; Joel Tardivel-Lacombe; Claude Chabret; Jean-Michel Arrang
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

3.  Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 4.  Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders.

Authors:  Patricia Di Ciano; Christian S Hendershot; Bernard Le Foll
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum.

Authors:  S J Taylor; G J Kilpatrick
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex.

Authors:  E Schlicker; A Behling; G Lümmen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

7.  Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes.

Authors:  J Clapham; G J Kilpatrick
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

8.  Characterization of histamine H3 receptors inhibiting 5-HT release from porcine enterochromaffin cells: further evidence for H3 receptor heterogeneity.

Authors:  H Schwörer; A Reimann; G Ramadori; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

9.  Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3-receptors in rat cerebral cortical membranes.

Authors:  E A Clark; S J Hill
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.